MacroGenics, Inc. (NASDAQ: MGNX) went up by 10.63% from its latest closing price when compared to the 1-year high value of $32.32, while MGNX stocks collected +3.27% of gains with the last five trading sessions.
MacroGenics, Inc. (NASDAQ: MGNX) Worth an Investment?
MacroGenics, Inc. (NASDAQ: MGNX) The 36 Months beta value for MGNX stocks is at 2.85, while 11 of the analysts out of 14 who provided ratings for MacroGenics, Inc. stocks as a “buy” while 0 as overweight, 3 rated it as hold and 0 as sell. The average price we get from analysts is $34.50 which is $16.36 above current price. MGNX currently has a short float of 8.97% and public float of 42.75M with average trading volume of 912.27K shares.
MGNX Market Performance
MGNX stocks went up by 3.27% for the week, with the monthly jump of 6.64% and a quarterly performance of -14.77%, while its annual performance rate touched -16.32%. The simple moving average for the period of the last 20 days is 6.06% for MGNX stocks with the simple moving average of -0.12% for the last 200 days.
Analysts’ Opinion on MacroGenics, Inc. (NASDAQ: MGNX)
Many brokerage firms have already submitted their reports for MGNX stocks, with Wedbush repeating the rating for MGNX shares by setting it to “Outperform”. The predicted price for MGNX socks in the upcoming period according to Wedbush is $26 based on the research report published on May 3, 2019.
Guggenheim, on the other hand, stated in their research note that they expect to see MGNX stock at the price of $26. The rating they have provided for MGNX stocks is “Neutral” according to the report published on April 12, 2019.
Citigroup gave “ Buy” rating to MGNX stocks, setting the target price at $26 in the report published on February 7, 2019.
MGNX Stocks -0.65% Far from 50 Day Moving Average
After a stumble in the market that brought MGNX to its low price for the period of the last 52 weeks, MacroGenics, Inc. was unable to take a rebound, for now settling with -44.31% of loss for the given period.
The stock volatility was left at 5.60%, however, within the period of a single month, the volatility rate increased by 6.49%, while the shares surge at the distance of +10.09% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -6.40% lower at the present time.
In the course of the last 5 trading sessions, MGNX went up by +3.27%, which changed the moving average for the period of 200 days to the total of -9.95% of losses for the stock in comparison to the 20-day moving average settled at $17.05. In addition, MacroGenics, Inc. saw 41.73% in overturn over the period of a single year with a tendency to cut further gains.
MGNX Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at MacroGenics, Inc. (MGNX), starting from Spitznagel Thomas, who sold 1,770 shares at the price of $30.00 back on Feb 06. After this action, Rushing now owns 0 shares of MacroGenics, Inc., valued at $53,100 with the latest closing price.
Peters Jeffrey Stuart, the General Counsel of MacroGenics, Inc., sold 68 shares at the value of $30.00 during a trade that took place back on Feb 06, which means that Peters Jeffrey Stuart is holding 202 shares at the value of $2,040 based on the most recent closing price.
MGNX Stock Fundamentals
The current profitability levels are settled at -284.77 for the present operating margin. The net margin for MacroGenics, Inc. stands at -285.18. Total capital return value is set at -63.16, while invested capital returns managed to touch -63.25. Equity return holds the value -57.70%, with -44.80% for asset returns.
The receivables turnover for MacroGenics, Inc. is 2.78 with the total asset turnover at the value of 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.49.